Pharmacokinetic Evaluation
PRECLINICAL PHARMACOKINETIC EVALUATION OF STARCH ACETATE AND CHITOSAN MICROPARTICLES OF GLIPIZIDE
... release) evaluation of microparticles of glipizide using i) starch acetate, a new modified starch and ii) chitosan, a new mucoadhesive polymer are reported ...preclinical pharmacokinetic evaluation ...
8
Pharmacokinetic Evaluation of a Gastrointestinal Motility Tretment of Drug in Healthy Human Volunteers (Cinitapride)
... “Pharmacokinetic evaluation of Gastro intestinal motility treatment of a drug in Human volunteers (Cinitapride)” forms my own contribution to the research work carried out under the guidance of ...
86
FORMULATION AND PHARMACOKINETIC EVALUATION OF RITONAVIR FLOATING TABLETS IN THE MANAGEMENT OF AIDS
... pharmacokinetic software (Pharsight Mountain View, CA USA). All values are expressed as the mean ± SD. Statistical analysis was performed with Graph Pad InStat software (version 3.00, Graph Pad Software, San ...
5
Synthesis, screening and pharmacokinetic evaluation of potential prodrugs of bupropion
... The pharmacological screens of N-methylbupropion versus bupropion showed that N-methylbupropion is less active than bupropion as a dopamine and norepinephrine reuptake inhibitor and coul[r] ...
26
PHARMACOKINETIC EVALUATION OF AMOXICILLIN ALONE AND SIMULTANEOUS ADMINISTRATION OF ANTACID
... study pharmacokinetic interaction between oral combination of amino penicillin ...compare pharmacokinetic parameters of amoxicillin alone and with simultaneous administration of antacid in an open one ...
6
Clinical and Pharmacokinetic Evaluation of Long-Term Therapy With Didanosine in Children with HIV Infection
... Zidovudine and didanosine combination therapy in children with human immunodeficiency virus infection. These regulations, along with the laws passed in 1936, 1968, and 1988, have[r] ...
10
IN-VIVO PHARMACOKINETIC EVALUATION OF DEVELOPED TRANSDERMAL PATCH OF ACECLOFENAC AND THIOCOLCHICOSIDE IN TREATMENT OF GOUT
... %CV except for the LLOQ, where it should not exceed 20% of the %CV. In accuracy study back calculated concentrations of all QC samples (HQC, MQC, and LQC) must be within 85.00-115.00% of their nominal concentration ...
17
Pharmacokinetic evaluation of D-ribose after oral and intravenous administration to healthy rabbits
... Healthy adult male V-line (Valencia) rabbits with a weight of 2–2.5 kg were obtained from the Alexandria University, Alexandria, Egypt. Rabbits were selected because they were widely used for pharmacokinetic ...
6
Formulation Tissue Distribution and Pharmacokinetic Evaluation of Salbutamol Sulphate Niosomes
... Formulation F4 Tween 80 + Chol shows three folds increase in drug distribution to lungs table 28 – table 30 when compared to Formulation F13 Span 60 + DCP and drug in solution.. In formu[r] ...
161
Pulmonary delivered polymeric micelles pharmacokinetic evaluation and biodistribution studies
... the pharmacokinetic experiment, a polyethylene catheter 204 (Portex Limited, Hythe, Kent, UK) was catheterized into the right 205 jugular veins of the rats under pentobarbital sodium anesthesia 206 (40 ...
12
Pharmacokinetic evaluation of intravenous artesunate in adults with uncomplicated falciparum malaria in Kenya: a phase II study
... Alternatives to treatment for severe malaria are needed in the USA and Europe for treatment of severe malaria. While nations in the Third World can choose to use AS preparations such as the Guilin AS product for ...
9
Pharmacokinetic Evaluation of Paclitaxel in South Indian Cancer Patients: A Prospective Study
... There are various e-Pub readers such as for Windows: Digital Editions, OS X: Calibre/Bookworm, iPhone/iPod Touch/iPad: Stanza, and Linux: Calibre/Bookworm. E-Book for desktop[r] ...
7
Formulation and pharmacokinetic evaluation of a paclitaxel nanosuspension for intravenous delivery
... the pharmacokinetic study, all female rats died after the injection of paclitaxel injection (15 mg/kg), and the male rats showed severe symptoms such as tremors and sticky plasma; while rats injected with ...
11
Development and pharmacokinetic evaluation of nebilolol solid dispersion using novel polymers
... The pharmacokinetic characteristics for Nebivolol pure drug suspension 10 mg, optimized preparation of solid dispersion 10 mg were evaluated using twelve healthy Male Wister rats weighing ...
13
Pharmacokinetic evaluation of a transdermal anastrozole-in-adhesive formulation
... The release profile of EA-based anastrozole TDDS was exam- ined by monitoring the drug permeation from 1% to 2.5% anastrozole patches, containing equimolar ratios of either PEG 4[r] ...
12
Efficacy and pharmacokinetic evaluation of a novel anti malarial compound (NP046) in a mouse model
... Background: Even though malaria is a completely preventable and treatable disease, it remains a threat to human life and a burden to the global economy due to the emergence of multiple-drug resistant malaria parasites. ...
7
DEVELOPMENT OF CONTROLLED RELEASE FORMULATION OF AN ANTIEMETIC DRUG USING NOVEL PARENTERAL DRUG DELIVERY SYSTEMS
... invivo pharmacokinetic evaluation showed increase in tmax, Cmax and AUC as compared to immediate release formulation which may be attributed to the slow diffusion of the drug from the polymeric ...
19
Pharmacokinetic and pharmacodynamic evaluation according to absorption differences in three formulations of ibuprofen
... for pharmacokinetic evaluation were obtained before dosing (0 hour) and ...for pharmacokinetic evaluation, 6 mL of blood was drawn into a sodium heparin tube and centrifuged at 3,000 rpm for ...
7
QUANTITATIVE STRUCTURE PHARMACOKINETIC RELATIONSHIP USING ARTIFICIAL NEURAL NETWORK: A REVIEW
... metabolism and excretion (ADME) properties and toxicity is often performed in-vitro or with various animals models which can be both time consuming and expensive. In addition existing model are limited by their high ...
10
Intravenous dosing of tocilizumab in patients younger than two years of age with systemic juvenile idiopathic arthritis: results from an open-label phase 1 clinical trial
... main evaluation period, and no additional safety signals were identified other than the higher incidence of serious hypersensitiv- ity in the main evaluation ...main evaluation period (faster than ...
10